Literature DB >> 12388300

Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes.

James N Tsoporis1, Alexander Marks, Linda J Van Eldik, David O'Hanlon, Thomas G Parker.   

Abstract

We previously reported that S100B, a 20-kDa Ca(2+)-binding homodimer, inhibited the postinfarct myocardial hypertrophic response mediated by alpha(1)-adrenergic stimulation through the protein kinase C (PKC) signaling pathway. In the present study, we examined whether the same pathway induced the S100B gene, supporting the hypothesis that S100B is a feedback negative regulator of this pathway. We transfected cultured neonatal rat cardiac myocytes with a luciferase reporter gene driven by the maximal human S100B promoter and progressively shorter segments of this promoter sequentially deleted from the 5' end. We identified a basic promoter essential for transcription spanning 162 bp upstream of the transcription initiation site and positive (at -782/-162 and -6,689/-4,463) and negative (at -4,463/-782) myocyte-selective regulatory elements. We showed that the basic and maximal S100B promoters were activated specifically by alpha(1)-adrenergic agonists through the alpha(1A)-adrenergic receptor, but not by any other trophic hormonal stimuli. The activation of the S100B promoter was mediated through the PKC signaling pathway. Transcription enhancer factor-1 (TEF-1) and related to TEF-1 (RTEF-1) influenced transcription from the maximal, but not the basic, promoter implicating active MCAT elements upstream from the basic promoter. Acting in opposing fashions, TEF-1 transrepressed the S100B promoter and RTEF-1 transactivated the promoter. Our results suggest that alpha(1)-adrenergic stimulation induces the S100B gene after myocardial infarction through the PKC signaling pathway and that this induction is modulated by TEF-1 and RTEF-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388300     DOI: 10.1152/ajpheart.00161.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  Influence of doxazosin on biosynthesis of S100A6 and atrial natriuretic factor peptides in the heart of spontaneously hypertensive rats.

Authors:  Irena Kasacka; Żaneta Piotrowska; Anna Filipek; Mariusz Majewski
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-28

2.  The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling.

Authors:  Sophie Debrus; Loulwa Rahbani; Minna Marttila; Bruno Delorme; Pierre Paradis; Mona Nemer
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

3.  Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.

Authors:  Masashi Kitazawa; David Cheng; Michelle R Tsukamoto; Maya A Koike; Paul D Wes; Vitaly Vasilevko; David H Cribbs; Frank M LaFerla
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

4.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26

Review 5.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

6.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Authors:  Guglielmo Sorci; Roberta Bianchi; Francesca Riuzzi; Claudia Tubaro; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-18

7.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07

Review 8.  S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.

Authors:  Carolin Kraus; David Rohde; Christian Weidenhammer; Gang Qiu; Sven T Pleger; Mirko Voelkers; Melanie Boerries; Andrew Remppis; Hugo A Katus; Patrick Most
Journal:  J Mol Cell Cardiol       Date:  2009-06-16       Impact factor: 5.000

9.  Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha.

Authors:  James N Tsoporis; Shehla Izhar; Thomas G Parker
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

10.  Is peripheral immunity regulated by blood-brain barrier permeability changes?

Authors:  Erin Bargerstock; Vikram Puvenna; Philip Iffland; Tatiana Falcone; Mohammad Hossain; Stephen Vetter; Shumei Man; Leah Dickstein; Nicola Marchi; Chaitali Ghosh; Juliana Carvalho-Tavares; Damir Janigro
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.